Atherosclerosis is primarily a disease of lipid metabolism and inflammation; however, it is also closely associated with endothelial extracellular matrix (ECM) remodelling, with fibronectin accumulating in the laminin-collagen basement membrane. To investigate how fibronectin modulates inflammation in arteries, we replaced the cytoplasmic tail of the fibronectin receptor integrin α5 with that of the collagen/laminin receptor integrin α2. This chimaera suppressed inflammatory signalling in endothelial cells on fibronectin and in knock-in mice. Fibronectin promoted inflammation by suppressing anti-inflammatory cAMP. cAMP was activated through endothelial prostacyclin secretion; however, this was ECM-independent. Instead, cells on fibronectin suppressed cAMP via enhanced phosphodiesterase (PDE) activity, through direct binding of integrin α5 to phosphodiesterase-4D5 (PDE4D5), which induced PP2A-dependent dephosphorylation of PDE4D5 on the inhibitory site Ser651. In vivo knockdown of PDE4D5 inhibited inflammation at athero-prone sites. These data elucidate a molecular mechanism linking ECM remodelling and inflammation, thereby identifying a new class of therapeutic targets.
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. Current concepts and clinical approaches focus mainly on these aspects. However, atherosclerotic plaques occur mainly in regions of arteries with disturbed flow 2, 3 , which triggers oxidative stress, activation of NF-κB and other mediators, endothelial inflammatory gene expression, and leukocyte recruitment 4 . These local influences synergize with systemic risk factors such as high plasma LDL-cholesterol and triglycerides, hypertension, diabetes or smoking, to induce atherosclerotic plaques 5 . Inflammation and ECM remodelling are closely associated across many biological systems and disease processes [6] [7] [8] . Inflammation induces ECM remodelling, with increases in provisional ECM proteins such as fibronectin (FN), osteopontin and fibrin. Conversely, ECM proteins and fragments modulate inflammatory processes. These complex interactions between ECM and inflammatory pathways contribute to normal developmental and adult remodelling, and to a variety of pathologies.
In stable, unperturbed vessels, the subendothelial basement membrane consists mainly of collagen IV, laminin and associated proteoglycans with minimal FN 9 . By contrast, FN expression and matrix assembly are upregulated during development, angiogenesis and flow-dependent vessel remodelling [10] [11] [12] . FN is also deposited in the intima at athero-prone regions of arteries 13 . This occurs even in athero-resistant wild-type (WT) mice, associated with endothelial inflammatory gene expression, indicating that it is an early event. FN increases in hypercholesterolemic mice together with atherosclerotic plaque progression. Studies in genetically modified mice support a causal role for FN in atherosclerosis [14] [15] [16] . In vitro studies with endothelial cells (ECs) showed that disturbed flow or acute changes in flow activate inflammatory pathways such as NF-κB, and induce expression of leukocyte recruitment molecules such as ICAM-1, MCP-1 and VCAM-1 17, 18 . However, these events depend strongly on the ECM proteins to which the ECs adhere: cells on collagen I or IV, or basement membrane protein (Matrigel) suppress NF-κB, JNK and PAK in response to flow and soluble inflammatory mediators but are activated in ECs on FN 13, [19] [20] [21] . Selective activation of cyclic AMP and protein kinase A (PKA) in cells on collagen or basement membrane protein relative to FN mediates the suppression of inflammatory pathways 22, 23 . But how different integrins control cAMP/PKA and inflammation is unknown. were stimulated with IL-1β or oxidized LDL for 30 min. NF-κB was assayed by western blotting for pSer536 p65 (e). t-p65, total p65. Quantification in f (n = 7) and g (n = 4) shows activation relative to control cells on FN without flow. (h) Effect of the chimaera on PKA activation. WT α5 or α5/2 chimaera cells on FN were sheared for 15 min and active PKA was pulled down from cell lysates with GST-PKI followed by immunoblotting. Forskolin (FSK) was used as a positive control for PKA activation (n = 4-8). (i) PKA inhibition rescues NF-κB activation in α5/2 chimaera cells. Chimaera cells on FN were treated with the PKI 14-22 amide inhibitor or dimethylsulfoxide (DMSO) alone, and then subjected to oscillatory shear for 18 h. Activation of NF-κB was assayed by western blotting (n = 4). Data are represented as means ± s.e.m. * P < 0.05 by one-way ANOVA (b,c,h,i) or two-tailed t-test (d,f,g). In all panels n values represent independent experiments. Source data are provided in Supplementary Table 1 . Unprocessed scans of blots are shown in Supplementary Fig. 6 .
The major FN receptor, α5β1, and the major collagen/laminin receptor, α2β1, that are strongly implicated in pro-versus antiinflammatory signalling in vitro and in vivo 24, 25 share the common β1 subunit. While α2β1 binds best to fibrillar collagens, it also serves as a functionally relevant receptor for collagen IV and laminins 26 . We therefore hypothesized that the cytoplasmic domains of the unique integrin alpha subunits may determine differential inflammatory signalling. In this study, we examined chimaeric integrin in which the cytoplasmic tail of integrin α5 was replaced by that of α2. Our results show that ECM-dependent differential inflammatory signalling is due to an interaction of the α5 cytoplasmic domain with the cAMP-specific phosphodiesterase PDE4D5, with consequent regulation of PDE4D5 phosphorylation, probably by protein phosphatase 2A (PP2A).
RESULTS
An integrin α5/2 chimaera blocks flow-dependent inflammatory signalling To examine ECM-specific signalling, we constructed a chimaeric integrin in which the α5 cytoplasmic tail was replaced with the α2 tail (Fig. 1a) . When over-expressed in bovine aortic endothelial cells (BAECs) the integrin α5/2 chimaera localized to the cell surface ( Supplementary Fig. 1a ) and hetero-dimerized with the integrin β1 subunit similarly to WT (Supplementary Fig. 1b) . Chimaera-expressing BAECs adhered and spread normally on FN ( Supplementary Fig. 1c and Fig. 2d,e) , and showed normal FAK activation, FN fibrillogenesis and alignment in laminar flow ( Supplementary Fig. 1d-f) . We then investigated shear-dependent inflammatory responses. The critical inflammatory transcription 28 29 loxP Cre transmembrane   210  220  230  240  250   T A  A A A  AAA A A AA A A A A A A A  C  CC C  C  C C  C  C  C  C  G  G  G G  G  G  T  T T  T  TT TT  T T Aortae from WT and chimaera knock-in homozygous mice were stained for the indicated proteins and the lesser curvature of the arch was examined. Staining intensity was quantified as described in Methods (n = 5 mice for each type). L, lumen. Data are represented as means ± s.e.m. * P < 0.05 by two-tailed t-test. Quantification data from individual mice are provided in Supplementary Table 1 .
factor NF-κB shows transient activation by onset of flow, and sustained activation by oscillatory flow 27, 28 . In both cases, the α5/2 chimaera blocked NF-κB activation (Fig. 1b,c) and expression of the NF-κB target gene product ICAM-1 (Fig. 1d) . We also noted that the α5/2 chimaera gave higher basal activation of NF-κB and other inflammatory pathways, but this also occurs with normal ECs on collagen or basement membrane protein 13, 21 . While this feature has not been further investigated, the combined results demonstrate that the α5/2 chimaera phenocopies cells on basement membranes.
ECM also modulates endothelial responses to soluble inflammatory mediators 19, 24 . IL-1β and oxidized LDL are two critical inflammatory mediators in atherosclerosis that also activate NF-κB. IL-1β and oxidized LDL strongly activated NF-κB in control ECs on FN, whereas control cells on Matrigel, or α5/2 chimaera cells on FN were largely resistant (Fig. 1e-g ). Previous results showed that selective activation of the cAMP/PKA pathway suppressed NF-κB on collagen IV-laminin basement membranes 22 . Shear stress activated PKA in cells expressing the α5/2 chimaera but not WT α5 on FN (Fig. 1h) . Furthermore, blocking PKA with PKI 14-22 amide, a cell-permeable PKA inhibitor, restored NF-κB activity in chimaera-expressing cells (Fig. 1i) . Together, these data show that differential PKA activation and subsequent inflammatory responses are mediated by the integrin α tails.
Integrin chimaera knock-in mice
To investigate the role of integrin α tails in vivo, we made knockin mice in which the exon encoding the endogenous integrin α5 cytoplasmic domain was replaced with that of integrin α2 following Cre-mediated recombination (Fig. 2a) . Breeding of α5/2-floxed-neo mice with CMV-Cre TG mice resulted in replacement of WT integrin α5 with the α5/2 chimaera (Fig. 2b,c) . These mice were viable and able to reproduce. A complete analysis of these mice will be reported elsewhere; in this study, we focused on endothelial phenotype. To confirm functionality, ECs isolated from WT and knock-in mice were plated on FN. The α5/2 cells showed no differences in adhesion or spreading (Fig. 2d,e) , confirming normal function. Endothelial inflammatory activation marked by elevated expression of FN, ICAM-1 and VCAM-1 occurs in regions of disturbed flow in WT C57Bl6 mice 13 and is a strong marker for susceptibility to atherosclerosis 29, 30 . Staining for these proteins in the athero-prone inner curvature of the aortic arch was greatly reduced in integrin α5/2 knock-in mice (Fig. 2f) . Thus, the integrin α5/2 chimaera suppresses flow-dependent early inflammation in vivo.
PGI 2 mediates flow-dependent cAMP/PKA activation
We next addressed how the ECM-integrin interaction modulates flow-dependent cAMP/PKA activation. The pathway by which flow activates cAMP and PKA is unknown; however, flow can induce PGI 2 (prostacyclin) secretion in ECs 31 , which binds a Gscoupled receptor to activate adenylate cyclase and induce cAMP production 32 , which promotes vasodilation and inhibits thrombosis and inflammation 33 . To test this pathway, human umbilical vein endothelial cells (HUVECs) on Matrigel were subject to flow with or without the cyclooxygenase (COX) inhibitor aspirin to block PGI 2 synthesis, or the PGI 2 receptor antagonist RO1138452 to block PGI 2 signalling. Both of these treatments efficiently inhibited shear stressdependent PKA activation (Fig. 3a) . They also conferred NF-κB activation by flow in cells on Matrigel (Fig. 3b,c) , confirming the importance of PKA in suppressing inflammatory pathways. Similarly, in α5/2 chimaera cells on FN, blocking prostacyclin synthesis (with indomethacin) or the PGI 2 receptor inhibited flow-induced PKA activation ( Fig. 3d ) and conferred NF-κB activation (Fig. 3e,f) . Thus, suppression of NF-κB by adhesion of cells to basement membranes is mediated by prostacyclin and its receptor.
Next, to test whether shear stress-dependent PGI 2 secretion is ECM-specific, we analysed the stable prostacyclin metabolite 6-keto-PGF1α, an approach that circumvents the instability of PGI 2 . Flow greatly increased 6-keto-PGF1α production, consistent with published data 31, 34 . However, 6-keto-PGF1α levels did not differ between FN and Matrigel (Fig. 3g) . Thus, prostacyclin production cannot account for the difference in cAMP and PKA activation in cells on different matrices.
PDE4D is required for ECM-specific NF-κB activation
We next considered whether differential cAMP degradation might mediate the observed ECM specificity. Phosphodiesterases (PDEs) are the enzymes that hydrolyse cAMP to reduce or terminate signalling 35, 36 . We focused on the PDE4 family, which are abundant in endothelial cells [37] [38] [39] [40] . We reasoned that if PDE4 is critical, its inhibition should restore PKA activation in endothelial cells on FN to levels similar to those on collagen or basement membranes. We first tested the PDE4 inhibitor rolipram, which increased shear-dependent PKA activation in cells on FN (Fig. 4a) and abolished flow-dependent NF-κB activation, without affecting NF-κB activity on collagen (Fig. 4b) . By contrast, flow-dependent AMPK activation was unaffected by ECM or rolipram ( Supplementary Fig. 2a ). PDE4 compartmentalization by protein-protein interactions mediates functional specificity in many systems 41 . Among the PDE4 sub-families, both PDE4C and PDE4D were reported in endothelial cells 42 . The PDE4D subfamily has eleven splicing variants; however, we used a panPDE4D antibody and a PDE4D5-specific antibody to show that PDE4D5 is the only isoform detected in HUVEC and BAEC cells (Supplementary Fig. 2b ).
We next examined whether PDE4D5 associates with integrins. Immunoprecipitation of endogenous PDE4D5 from HUVECs with two different antibodies brought down α5 but not α2 integrin (Fig. 4c) . Immunoprecipitating WT α5 or the α5/2 chimaera showed that this interaction required the α5 cytoplasmic domain (Fig. 4d) . To investigate PDE4D function in flow-dependent NF-κB activation, we performed knockdown and reconstitution experiments. PDE4D knockdown almost completely abolished shear stress-dependent NF-κB activation in cells on FN, which was rescued by an short interfering RNA (siRNA)-resistant construct (Fig. 4e) . To test whether targeting PDE4D5 to focal adhesion is sufficient for these effects, we fused the focal adhesion targeting domain of FAK to PDE4D5 43 . This construct strongly localized to focal adhesions in cells on Matrigel ( Supplementary Fig. 2c ) and conferred flow-induced NF-κB activation (Fig. 4f) . This construct also reduced shear stress-dependent Creb phosphorylation, confirming suppression of PKA activity.
Direct interaction between the PDE4D5 UCR2 linker and integrin α5
We next mapped the integrin-binding region in PDE4D5 using bacterially expressed and purified fragments of PDE4D5 (Fig. 5a ) to pull down integrin α5 from cell lysates. Binding was observed only with the regulatory upstream conserved region 2 (UCR2) with flanking connecting segments (Fig. 5b) . Using purified integrin α tail fusion proteins that form coiled coil domain-mediated homodimers 44 , only integrin α5 bound the purified PDE4D5 F2 fragment, indicating that the association is direct and specific (Fig. 5c) . Examining a series of deletions (Fig. 5d) showed that the carboxy-terminal 13 amino acids from GST-F1-F2 are required for the interaction (Fig. 5e ). Among those 13 amino acids, mutation of K 292 KKR 295 to either EEEE or AAAA completely blocked, and single amino acid substitutions partially blocked, the interaction (Fig. 5f ). Thus, a short, basic sequence in the connecting segment between UCR2 and the catalytic domain is required for binding integrin α5.
To further validate this interaction, cells expressing WT or mutated GFP-PDE4D5 were plated on FN or collagen, then subject to flow for 15 min. In cells on FN, WT PDE4D5 but not PDE4D5 with a mutated α5-binding sequence co-localized with the focal adhesion marker vinculin; co-localization was also lost in cells on collagen (Fig. 5g) . Thus, the interaction with α5 specifically recruits PDE4D5 to focal adhesions.
Integrin α5 binding is required for NF-κB activation on FN
To address whether the interaction between integrin α5 and PDE4D5 is required for pro-inflammatory signalling in cells on FN, we reconstituted PDE4D5 knockdown cells with WT or mutant PDE4D5. Whereas the WT PDE4D5 construct recovered NF-κB activation, 4E and 4A mutants were inactive, as was catalytically dead PDE4D5 (D556A) (Fig. 5h) . Thus, PDE4D binding to integrin α5 and catalytic activity are required for inflammatory signalling. Together, these results show that recruitment of PDE4D5 to focal adhesions via α5 binding mediates its pro-inflammatory function by suppressing antiinflammatory PKA activation.
Regulation of PDE4D phosphorylation by integrin α5
We then considered whether localization of PDE4D5 by integrin α5 is the sole determinant of these effects or whether PDE4 catalytic activity is affected. Assaying catalytic activity of purified PDE4D in vitro after addition of recombinant integrin α5 tails revealed no changes. PDE4D5 activity is also regulated by phosphorylation; one important site is Ser651, which can be phosphorylated by Erk and suppresses enzymatic activity 45 . Western blotting with an antibody against this site showed that Ser651 phosphorylation increased in cells on collagen compared with FN, independent of fluid shear stress. Further, the reduced phosphorylation on FN was lost in the 4E mutant (Fig. 6a) . Cells expressing the chimaeric integrin α5/2 plated on FN also showed high Ser651 PDE4D phosphorylation compared with WT α5 cells (Fig. 6b) . These data suggest either that the integrin α5-PDE4D interaction suppresses Ser651 phosphorylation or that integrin α2 activates it. Analysis of cells expressing WT or 4E mutant PDE4D5 were analysed in suspension or after adhesion to FN-coated dishes. Plating on FN triggered Ser651 dephosphorylation in WT PDE4D5 but not the 4E mutant (Fig. 6c) . Chimaeric integrin α5/2 also failed to trigger Ser651 dephosphorylation on FN (Fig. 6c) . Thus, binding to integrin α5 in cells on FN induces PDE4D5 Ser651 dephosphorylation.
Proteomic analysis revealed PP2A in PDE4D5 immunoprecipitates in ECs on FN (Supplementary Fig. 3a) . Co-immunoprecipitation confirmed this interaction in cells on FN but not Matrigel ( Supplementary  Fig. 3b ). Both the PP2A inhibitor okadaic acid (OA) and siRNA against the PP2A catalytic subunit blocked FN-dependent Ser651 dephosphorylation after plating on FN (Supplementary Fig. 3c ) and in stable monolayers ( Supplementary Fig. 3d ,e) without affecting endothelial cell adhesion, spreading or FAK activation on FN ( Supplementary  Fig. 4a,b) . However, these treatments efficiently blocked NF-κB activation by flow and IL1β on FN ( Supplementary Fig. 3f,g ). Similar results were obtained in 4 experiments. (e) BAECs were transfected with siRNA against PDE4D and then rescued with control or PDE4D5-GFP retrovirus. Cells were subjected to oscillatory shear and NF-κB assayed as before (n = 4). (f) BAECs expressing WT PDE4D5 or FAT-PDE4D5 were plated on Matrigel for 5 h and subjected to oscillatory shear. NF-κB Ser536 phosphorylation and Creb Ser133 phosphorylation were measured by western blotting (n = 4). Data are represented as means ± s.e.m. * P < 0.05 by oneway ANOVA (a,e,f) or two-tailed t-test (b). In all panels n values represent independent experiments. Source data are provided in Supplementary  Table 1 . Unprocessed scans of blots are shown in Supplementary Fig. 6 .
We next addressed whether Ser651 phosphorylation controls ECM-specific NF-κB activation. For ECs on collagen, expression of phospho-resistant S651A mutant in PDE4D knockdown cells increased NF-κB activity (Fig. 6d) . Conversely, in cells on FN, rescue of PDE4D5 knock down with phospho-mimetic S651E mutant failed to restore NF-κB activation (Fig. 6e) . These results show that control of PDE4D5 phosphorylation on Ser651 by integrins determines subsequent inflammatory signalling.
Endothelial-specific knockdown of PDE4D inhibits inflammation
We next investigated whether PDE4D is required for flow-dependent inflammatory activation of the endothelium in vivo using siRNA. For these experiments, we used recently developed nanoparticles that are highly specific to ECs and do not knock down genes in haematopoietic cells, including leukocytes, or in hepatocytes, even at a high dose (2.0 mg kg −1 ) 46 . We first screened multiple (h) BAECs stably expressing integrin α5 binding-deficient PDE4D5 mutants (4A and 4E) or the catalytically inactive mutant (D556A) were transfected with siRNA to knock down the endogenous PDE4D, and then were subjected to oscillatory shear for 18 h. NF-κB activity was assayed as in Fig. 1 ; (n = 3 independent experiments). Data are represented as means ± s.e.m. * P < 0.05 by two-tailed t-test. Source data are provided in Supplementary Table 1 . Unprocessed scans of blots are shown in Supplementary Fig. 6 .
siRNAs and identified a sequence that depleted mouse PDE4D in vitro with an IC 50 of 0.05 nM ( Supplementary Fig. 5a ), which is ∼100× lower than most siRNAs. Transfection into cultured mouse ECs abolished flow-dependent NF-κB activation and ICAM-1 induction, which was rescued by viral expression of human PDE4D5 (Fig. 7a) , thus, confirming the efficacy and specificity of this siRNA sequence. A version of this siRNA was chemically modified to improve stability and packaged into nanoparticles, then injected intravenously into mice (1.0 mg kg −1 ). Isolation of aortic endothelial messenger RNA 14 days after injection showed a ∼70% decrease in PDE4D mRNA compared with the luciferase control siRNA (Supplementary Fig. 5b) . C57BL6 mice were then injected three times in a month with PDE4D or luciferase siRNA nanoparticles. The PDE4D siRNA greatly reduced inflammatory gene expression in an athero-prone artery segment compared with luciferase siRNA (Fig. 7b) . BAECs expressing WT integrin α5 or the α5/2 chimaera on FN were transfected with PDE4D5, and then sheared for 15 min. Ser651 phosphorylation was assayed by western blotting as in a (n = 3). (c) BAECs expressing PDE4D5 WT or the 4E mutant or chimaera cells expressing PDE4D5 WT were kept in suspension (Sus.) for 90 min and then replated on FN-coated dishes for the indicated times. Ser651 phosphorylation was assayed by western blotting (n = 3). (d,e) BAECs in which endogenous PDE4D5 was knocked down were reconstituted with WT, phospho-deficient S651A or phosphomimetic S651E mutants. The cells were replated on collagen (d) (n = 3) or FN (e) (n = 6) and then subjected to oscillatory shear for 2 h. NF-κB activity was assayed as in Fig. 1 . In all panels n values represent independent experiments. Data are represented as means ± s.e.m. * P < 0.05 by oneway ANOVA (a,b,d) or two-tailed t-test (c,e). Source data are provided in Supplementary Table 1 . Unprocessed scans of blots are shown in Supplementary Fig. 6 .
Effects on atherosclerosis
Lastly, we investigated atherosclerosis in the integrin α5/2 chimaeric mice by breeding onto the hypercholesterolemic ApoE −/− background, which, on a high-fat, 'Western' diet, develop atherosclerotic plaques at regions of disturbed flow, similar to human disease 47 . Aortae from these mice after 4 months on a high-fat diet showed dramatically decreased plaque burden (Fig. 7c) . These results validate the connection between early inflammatory activation of the endothelium by disturbed shear and later disease progression in hyperlipidaemia.
DISCUSSION
Inflammation has frequently been described as a double-edged sword that is required for tissue defence, remodelling and repair but, if not properly regulated, causes damage or disease 48, 49 . Inflammatory Table 1 . (b) Nanoparticles containing PDE4D siRNA or luciferase (LUC) siRNA (1 mg kg −1 ) were injected intravenously. Aortae from treated mice were isolated and stained for the indicated molecules to assay inflammatory markers in lesser curvature (n = 5 mice). (c) Integrin chimaera knock-in mice were bred with ApoE null mice and fed a high-fat diet for 4 months. Aortae were opened and stained en face with Sudan IV (n = 4 mice). Plaque area and numbers were quantified. Data are represented as means ± s.e.m. * P < 0.05 by two-tailed t-test. Quantification data from individual mice are provided in Supplementary Table 1. reactions therefore need to be initiated following infection, injury or stress, but then resolved when the infection is cured, injury healed or stress relieved. Linking the biochemical and structural changes associated with tissue repair and remodelling with the pathways that govern inflammation appears to be essential for proper regulation of these processes 50, 51 . Vascular remodelling to adapt to changes in tissue demand requires inflammatory activation of the endothelium and recruitment of leukocytes, mainly monocytes, which aid in remodelling 6, 7 . These processes also involve degradation of basement membranes and synthesis of a provisional, FN-rich ECM. Once morphogenesis is completed, new basement membrane synthesis is a key part of the resolution phase for formation of stable, quiescent vessels 52, 53 . Atherosclerosis may be considered a form of pathological flow-dependent remodelling where ECs in regions of disturbed flow undergo inflammatory activation but can never adapt to restore quiescence 54 . WT mice show chronic inflammatory activation of the endothelium in regions of disturbed flow 55 that, when other risk factors are present, progresses to atherosclerosis. FN deposition beneath the endothelium is an early event in this process, appearing first in the regions of low-grade inflammation in WT mice and increasing in atherosclerosis 13 . FN in the endothelial layer is also abundant in lesions from human arteries 56 . Moreover, several genetic manipulations that reduce FN in the vessel wall reduce atherosclerosis in mice [14] [15] [16] , as does an antagonist of integrin α5β1 (ref. 24) . Interestingly, while classic genetic studies that searched for single genes that affect artery disease identified mainly lipid metabolism and inflammatory genes, a recent analysis of gene networks identified ECM and ECM remodelling gene networks as equivalently important 57 . Thus, genetic analysis supports a role for tight integration of inflammatory and ECM pathways in vascular remodelling.
Previous work showed that in cells on collagen or basement membrane, flow-induced activation of the cAMP/PKA pathway inhibits inflammatory activation of the endothelium 22 . Recent work has also identified PKA-independent anti-inflammatory actions of cAMP on inflammasome assembly [58] [59] [60] . The provisional FN-rich ECM relieves this inhibition and allows inflammatory activation. Our data show that these effects are mediated through direct binding of PDE4D5 to the integrin α5 tail. This interaction localizes PDE4D5 to focal adhesions, induces its proximity to PP2A, with subsequent dephosphorylation on an inhibitory site. This dephosphorylation increases enzymatic activity to decrease cAMP levels and increase endothelial inflammatory activation. These effects were observed both in vitro and in vivo, the latter in mice where the integrin α5 cytoplasmic domain was replaced with that of α2, and after knockdown of PDE4D5.
Ser651 of PDE4D5 is potentially phosphorylated by Erk2 (ref. 45 ). However, in cells on collagen or basement membrane, Ser651 phosphorylation was high in both high and low serum, and was unaffected by the MEK inhibitor U0126 despite large changes in Erk activity, and was adhesion-independent. Instead, PDE4D5 Ser651 phosphorylation was controlled by matrix-specific, PP2A-dependent dephosphorylation. Thus, plating cells on FN or shear stress-dependent integrin activation results in recruitment of PDE4D5 into focal adhesions and dephosphorylation of Ser651.
A number of anti-inflammation drugs are in development or clinical trial for treatment of atherosclerosis 61 . Interestingly, both genetic deletion of plasma FN and an integrin α5β1 antagonist reduced atherosclerotic plaque development in mouse models 16, 23 . However, FN contributes to haemostasis, fibrosis and other essential functions; thus, its systemic inhibition is unlikely to be clinically viable 62, 63 . The integrin α5-PDE4D interaction may therefore provide a more specific target to inhibit plaque progression without globally affecting FN function. It should also bypass adverse effects of PDE4 catalytic inhibitors 35 . Further studies will be required to understand how the molecular events and interactions defined here play out during the complex physiology and pathology of vessel remodelling, atherosclerosis and other instances of chronic inflammation.
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of this paper.
Note: Supplementary Information is available in the online version of the paper FN for 30 min and lysed for immunoprecipitation with FLAG antibody. FLAG peptides were used to elute from immune complexes from control non-infected cells and PDE4D5-expressing cells. After SDS-PAGE and silver staining, specific bands were excised and submitted to Yale Keck Biotechnology Resource Laboratory for LC-MS/MS analysis.
In vitro binding assays. For the binding assay using integrin tails on beads, 30 µg of integrin α tail proteins were incubated with 6 µl of cobalt beads (Clontech). Washed beads were incubated with 100 ng of purified PDE4D5 fragment for 1 h in buffer containing 20 mM PIPES pH 6.8, 1% TX-100, 150 mM NaCl, 150 mM sucrose. For GST-pulldown analysis for PDE4D domain mapping, 5 µg of GST fusion proteins on GSH-agarose beads were incubated with 100 ng of purified integrin α5 tail proteins in buffer containing 20 mM PIPES pH 6.8, 1% TX-100, 150 mM NaCl, 150 mM sucrose and 1 mg ml −1 BSA for 1 h at 4 • C, then washed and analysed by SDS-PAGE and western blotting.
Cell adhesion and spreading assay. Cells were detached and replated on dishes coated with either poly-L-lysine or FN (10 µg ml −1 ) for 15 min. Adherent cells were quantified using the acid phosphatase assay 70 and normalized to the cells attached on PLL-coated dishes for 1 h. To assess cell spreading, cells plated for the indicated times were fixed and stained with Alexa Fluor 488-conjugated wheat germ agglutinin (Invitrogen, 5 µg ml −1 ), imaged with spinning-disc confocal microscopy (Nikon) and cell areas were quantified using ImageJ software.
Fibronectin fibrillogenesis assay. WT or α5/2 cells were plated on FN-coated coverslips and grown until they formed monolayers. Cells were incubated with 1 % FBS containing media for three days, fixed and then stained with anti-FN antibody (Sigma). 
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